These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8821041)

  • 21. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From transplants to gene therapy for Parkinson's disease.
    Freeman TB
    Exp Neurol; 1997 Mar; 144(1):47-50. PubMed ID: 9126151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
    Friedman A; Galazka-Friedman J
    Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease.
    Witt SN; Flower TR
    FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Parkinson's disease.
    Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125
    [No Abstract]   [Full Text] [Related]  

  • 31. Optogenetic neuromodulation.
    Kalanithi PS; Henderson JM
    Int Rev Neurobiol; 2012; 107():185-205. PubMed ID: 23206683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathology of Parkinson's disease].
    Arnoud B
    Soins; 1986 Mar; (474):3-6. PubMed ID: 2875524
    [No Abstract]   [Full Text] [Related]  

  • 33. Mitogenic neurotransmitters.
    Hanley MR
    Nature; 1989 Jul; 340(6229):97. PubMed ID: 2567964
    [No Abstract]   [Full Text] [Related]  

  • 34. The locus coeruleus: Another vulnerability target in Parkinson's disease.
    Oertel WH; Henrich MT; Janzen A; Geibl FF
    Mov Disord; 2019 Oct; 34(10):1423-1429. PubMed ID: 31291485
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neurochemical methods].
    Agid Y
    Rev Electroencephalogr Neurophysiol Clin; 1976; 6(4):444-6. PubMed ID: 14358
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormones, autacoids, neurotransmitters, and growth factors.
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):137-55. PubMed ID: 7922160
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance of cyclic nucleotides in neurochemistry].
    Stavljenić A; Hajnsek F; Gubarev N
    Neurologija; 1984; 32(1-2):45-52. PubMed ID: 6147771
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinson's disease--II. Aging and neuroendocrine relationships.
    Adv Exp Med Biol; 1978; 113():iii-xii, 1-270. PubMed ID: 37712
    [No Abstract]   [Full Text] [Related]  

  • 39. Guest Editorial.
    Chinopoulos C; Starkov A
    Neurochem Res; 2019 Oct; 44(10):2237-2238. PubMed ID: 31486965
    [No Abstract]   [Full Text] [Related]  

  • 40. Breathing without acetylcholinesterase.
    Chatonnet F; Boudinot E; Chatonnet A; Champagnat J; Foutz AS
    Adv Exp Med Biol; 2004; 551():165-70. PubMed ID: 15602959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.